VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Transient elastography & other techniques | Raj Vuppalanchi, MBBSView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017MRI; what can it deliver | Claude Sirlin, MDView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Circulating nucleic acids and combination panels | Sven Francque, MD, PhDView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Role of genetic assessments | Quentin Anstee, BSc, MB BS, PhD, MRCP(UK), FRCPView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Collaboration in action - Innovative Medicines Initiative | Quentin Anstee, BSc, MB BS, PhD, MRCP(UK), FRCPView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Collaboration in action - Foundation for the National Institutes of Health | Roberto Calle, MD, FACE, FACPView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Innovation in histological assessment of NASH | Pierre Bedossa, MD, PhDView Video
VideoViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2017Opening lecture: A pathologist, a radiologist and a hepatologist walked into a bar | Brent Neuschwander-Tetri, MDView Video
VideoRespiDART 2018Discovery and development of novel and potent non-fusion inhibitors of RSV | Michael Rhodin, PhDView Video
VideoRespiDART 20183D Human epithelial models to study respiratory virus pathogenesis | Samuel Constant, PhDView Video
VideoRespiDART 2018Difficulties and barriers in developing RSV polymerase inhibitors | Rachel Fearns, PhDView Video
